The Drug Development Chain (Discoveryà R&D-à Pre-Clinical testingà Clinical Testingà Regulatory ApprovalàMarket Release) is the long, arduous, and expensive process that a therapy takes from idea to cure. The process requires experts from a broad spectrum of disciplines and the ability to collect, analyze, and collate data housed in multiple internal and external systems that do not readily communicate with each other.
Due to the need to create an immutable, transparent, authenticated, and auditable record of the events and data collected during this process, the Drug Development Chain, like the Information Supply Chain or the Pharmaceutical Supply Chain, can leverage ADLT™ to accomplish these goals as well as provide a connection between the pre- and post-marketing research that is conducted.
The ability to have a longitudinal view of drug development and post marketing use can have a major impact on future development as the industry looks for ways to improve R&D, look for unmet niches, and pave the way for decentralized manufacturing and personalized medicine.
One of the most powerful features of ADLT™ is the capability to bridge existing systems and processes while allowing access to data, like patient adherence information, that has not been easily accessible in the past.